Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
The current price of CDIOW is $0.02 USD — it has increased by +26.83% in the past 24 hours. Watch Cardio Diagnostics stock price performance more closely on the chart.
What is Cardio Diagnostics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Cardio Diagnostics stocks are traded under the ticker CDIOW.
Is Cardio Diagnostics stock price growing?▼
CDIOW stock has fallen by -13.81% compared to the previous week, the month change is a -55.3% fall, over the last year Cardio Diagnostics has showed a -54.12% decrease.
What is Cardio Diagnostics market cap?▼
Today Cardio Diagnostics has the market capitalization of 28,485.6
When is the next Cardio Diagnostics earnings date?▼
Cardio Diagnostics is going to release the next earnings report on June 03, 2026.
What is Cardio Diagnostics revenue for the last year?▼
Cardio Diagnostics revenue for the last year amounts to 70,000 USD.
What is Cardio Diagnostics net income for the last year?▼
CDIOW net income for the last year is -16.77M USD.
How many employees does Cardio Diagnostics have?▼
As of April 02, 2026, the company has 13 employees.
In which sector is Cardio Diagnostics located?▼
Cardio Diagnostics operates in the Health Care sector.
When did Cardio Diagnostics complete a stock split?▼
Cardio Diagnostics has not had any recent stock splits.
Where is Cardio Diagnostics headquartered?▼
Cardio Diagnostics is headquartered in Chicago, US.